These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29123445)

  • 1. Acute Exacerbation of Idiopathic Pulmonary Fibrosis.
    Kishaba T
    Eurasian J Med; 2017 Oct; 49(3):204-206. PubMed ID: 29123445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute exacerbation of idiopathic pulmonary fibrosis triggered by
    Suzuki A; Kimura T; Kataoka K; Matsuda T; Yokoyama T; Mori Y; Kondoh Y
    Respir Med Case Rep; 2018; 23():103-106. PubMed ID: 29719792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute Exacerbation of Idiopathic Pulmonary Fibrosis.
    Kishaba T
    Medicina (Kaunas); 2019 Mar; 55(3):. PubMed ID: 30884853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute exacerbations of idiopathic pulmonary fibrosis (AE-IPF): an overview of current and future therapeutic strategies.
    Biondini D; Balestro E; Sverzellati N; Cocconcelli E; Bernardinello N; Ryerson CJ; Spagnolo P
    Expert Rev Respir Med; 2020 Apr; 14(4):405-414. PubMed ID: 31994940
    [No Abstract]   [Full Text] [Related]  

  • 5. Outcomes with newly proposed classification of acute respiratory deterioration in idiopathic pulmonary fibrosis.
    Teramachi R; Kondoh Y; Kataoka K; Taniguchi H; Matsuda T; Kimura T; Yokoyama T; Yamano Y; Furukawa T; Sakamoto K; Hashimoto N; Hasegawa Y
    Respir Med; 2018 Oct; 143():147-152. PubMed ID: 30261987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study protocol: exploring the efficacy of cyclophosphamide added to corticosteroids for treating acute exacerbation of idiopathic pulmonary fibrosis; a randomized double-blind, placebo-controlled, multi-center phase III trial (EXAFIP).
    Naccache JM; Montil M; Cadranel J; Cachanado M; Cottin V; Crestani B; Valeyre D; Wallaert B; Simon T; Nunes H
    BMC Pulm Med; 2019 Apr; 19(1):75. PubMed ID: 30971235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute exacerbation of idiopathic pulmonary fibrosis induced by pertussis: the first case report.
    Hirai K; Homma T; Yamaguchi F; Yamaguchi M; Suzuki S; Tanaka A; Ohnishi T; Sagara H
    BMC Pulm Med; 2019 Jan; 19(1):15. PubMed ID: 30642317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time for Prevention of Idiopathic Pulmonary Fibrosis Exacerbation.
    Richeldi L
    Ann Am Thorac Soc; 2015 Nov; 12 Suppl 2():S181-5. PubMed ID: 26595737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Characteristics Based on the New Criteria of Acute Exacerbation in Patients with Idiopathic Pulmonary Fibrosis.
    Kishaba T; Nei Y; Momose M; Nagano H; Yamashiro S
    Eurasian J Med; 2018 Feb; 50(1):6-10. PubMed ID: 29531483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute exacerbation of idiopathic pulmonary fibrosis a narrative review primary focus on treatments.
    Luo X; Xiang F
    J Thorac Dis; 2024 Jul; 16(7):4727-4741. PubMed ID: 39144320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute exacerbation of idiopathic pulmonary fibrosis: lessons learned from acute respiratory distress syndrome?
    Marchioni A; Tonelli R; Ball L; Fantini R; Castaniere I; Cerri S; Luppi F; Malerba M; Pelosi P; Clini E
    Crit Care; 2018 Mar; 22(1):80. PubMed ID: 29566734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of corticosteroid and intravenous cyclophosphamide in acute exacerbation of idiopathic pulmonary fibrosis: A propensity score-matched analysis.
    Hozumi H; Hasegawa H; Miyashita K; Yasui H; Suzuki Y; Kono M; Karayama M; Furuhashi K; Hashimoto D; Enomoto N; Fujisawa T; Inui N; Nakamura Y; Yokomura K; Nakamura H; Suda T
    Respirology; 2019 Aug; 24(8):792-798. PubMed ID: 30803100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute exacerbation of idiopathic pulmonary fibrosis: shifting the paradigm.
    Ryerson CJ; Cottin V; Brown KK; Collard HR
    Eur Respir J; 2015 Aug; 46(2):512-20. PubMed ID: 26232481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for acute exacerbation of idiopathic pulmonary fibrosis: A systematic review and meta-analysis.
    Qiu M; Chen Y; Ye Q
    Clin Respir J; 2018 Mar; 12(3):1084-1092. PubMed ID: 28332341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute exacerbation of idiopathic pulmonary fibrosis: a 10-year single-centre retrospective study.
    Yamazoe M; Tomioka H
    BMJ Open Respir Res; 2018; 5(1):e000342. PubMed ID: 30397488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19-Triggered Acute Exacerbation of IPF, an Underdiagnosed Clinical Entity With Two-Peaked Respiratory Failure: A Case Report and Literature Review.
    Goto Y; Sakamoto K; Fukihara J; Suzuki A; Omote N; Ando A; Shindo Y; Hashimoto N
    Front Med (Lausanne); 2022; 9():815924. PubMed ID: 35187001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute exacerbation of idiopathic pulmonary fibrosis: who to treat, how to treat.
    Kulkarni T; Duncan SR
    Curr Pulmonol Rep; 2019 Dec; 8(4):123-130. PubMed ID: 33312849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic Role of Recombinant Human Soluble Thrombomodulin for Acute Exacerbation of Idiopathic Pulmonary Fibrosis.
    Isshiki T; Sakamoto S; Homma S
    Medicina (Kaunas); 2019 May; 55(5):. PubMed ID: 31137593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in clinical features of acute exacerbation between connective tissue disease-associated interstitial pneumonia and idiopathic pulmonary fibrosis.
    Enomoto N; Oyama Y; Enomoto Y; Yasui H; Karayama M; Kono M; Hozumi H; Suzuki Y; Furuhashi K; Fujisawa T; Inui N; Nakamura Y; Suda T
    Chron Respir Dis; 2019; 16():1479972318809476. PubMed ID: 30380910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase II trial evaluating the efficacy and safety of perioperative pirfenidone for prevention of acute exacerbation of idiopathic pulmonary fibrosis in lung cancer patients undergoing pulmonary resection: West Japan Oncology Group 6711 L (PEOPLE Study).
    Iwata T; Yoshino I; Yoshida S; Ikeda N; Tsuboi M; Asato Y; Katakami N; Sakamoto K; Yamashita Y; Okami J; Mitsudomi T; Yamashita M; Yokouchi H; Okubo K; Okada M; Takenoyama M; Chida M; Tomii K; Matsuura M; Azuma A; Iwasawa T; Kuwano K; Sakai S; Hiroshima K; Fukuoka J; Yoshimura K; Tada H; Nakagawa K; Nakanishi Y;
    Respir Res; 2016 Jul; 17(1):90. PubMed ID: 27450274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.